Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net earnings (loss)	$ 245.9	$ (3.7)
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Depreciation and amortization	1,263.0	1,471.6
Share-based Compensation	49.8	50.9
Deferred income tax benefit	(210.4)	(158.0)
Loss from equity method investments	37.4	43.6
Other non-cash items	134.3	124.2
Litigation settlements and other contingencies, net	43.6	13.5
Changes in operating assets and liabilities:
Accounts receivable	(27.3)	(20.7)
Inventories	(532.4)	(477.6)
Accounts payable	(99.7)	(83.2)
Income taxes	115.2	(60.2)
Other operating assets and liabilities, net	176.2	216.6
Net cash provided by operating activities	1,195.6	1,117.0
Cash flows from investing activities:
Cash paid for acquisitions, net	0.0	(148.7)
Capital expenditures	(126.1)	(139.6)
Purchase of available for sale securities and other investments	(96.1)	(19.5)
Proceeds from the sale of marketable securities	38.6	19.1
Payments for product rights and other, net	(97.3)	(146.5)
Proceeds from the sale of assets	2.1	24.3
Net cash used in investing activities	(278.8)	(410.9)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	33.2	6.4
Payments of long-term debt	(588.9)	(657.1)
Non-contingent payments for product rights	(139.5)	0.0
Change in short-term borrowings, net	0.3	(1.9)
Taxes paid related to net share settlement of equity awards	(7.1)	(8.4)
Contingent consideration payments	(48.5)	(47.8)
Payments of financing fees	(1.8)	(2.7)
Proceeds from exercise of stock options	0.6	8.0
Other items, net	(3.1)	(1.1)
Net cash used in financing activities	(754.8)	(704.6)
Effect on cash of changes in exchange rates	14.0	(16.4)
Net increase (decrease) in cash, cash equivalents and restricted cash	176.0	(14.9)
Cash, cash equivalents and restricted cash — beginning of period	491.1	389.3
Cash, cash equivalents and restricted cash — end of period	$ 667.1	$ 374.4